DavidSHanMD

Family Medicine • Glendale, CA

Shalom Medical Corporation

Join to view full profile

Dr. Han is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Han's full profile

Already have an account?

Office
1901 Broadview Drive
Glendale, CA 91208
Phone+1 818-246-3306

Fax+1 818-246-3333
Is this information wrong?

Summary

Dr. David Han is a family physician in Glendale, CA and is affiliated with multiple hospitals in the area, including Adventist Health Glendale, Glendale Memorial Hospital and Health Center, and USC Verdugo Hills Hospital. He received his medical degree from St. George's University School of Medicine and has been in practice 16 years. He also speaks multiple languages, including Korean.

Education & Training

Adventist Health GlendaleResidency, Family Medicine, 2003 - 2006
St. George's University School of MedicineClass of 2003

Certifications & Licensure

CA State Medical License 2005 - 2024
American Board of Family Medicine Family Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2014

Clinical Trials

Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189 Start of enrollment: 2011 Feb 01
Completed
Phase 1
A Single and Multiple Dose Study to Assess Blood and Urine Drug Levels of Fostamatinib in Healthy Japanese Subjects Start of enrollment: 2012 Jun 01
Completed
Phase 1
A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients Start of enrollment: 2013 Mar 01
Completed
Phase 1
AZD6423 SAD/MAD Study in Healthy Volunteers Start of enrollment: 2013 Sep 01
Completed
Phase 1
A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers Start of enrollment: 2013 Aug 01
Completed
Phase 1
SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease. Start of enrollment: 2014 Feb 04
Completed
Phase 1
Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects Start of enrollment: 2014 Dec 01
Completed
Phase 1
A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease Start of enrollment: 2017 May 15
Completed
Phase 1
A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects Start of enrollment: 2019 Jan 16
Completed
Phase 1
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy Subjects Start of enrollment: 2019 Jul 24
Terminated
Phase 1
A Study to Evaluate the Pharmacokinetics,Safety and Tolerability of Y-2 Sublingual Tablet in Healthy Adult Subjects Start of enrollment: 2023 Sep 06
Completed
Phase 1
A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects Start of enrollment: 2019 Oct 28
Completed
Phase 1
To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia Start of enrollment: 2019 Nov 21
Completed
Phase 1
A Study to Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney Disease Start of enrollment: 2020 Jul 22
Completed
Phase 1
A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects Start of enrollment: 2022 Aug 30
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

1 citations
Single- and Multiple-dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP1128, a Novel Peroxisome Proliferator-activated Receptor δ Modulator, in H...
Yuta Taniuchi, J W Olivier van Till, Tomasz Wojtkowski, Junko Toyoshima, Akira Koibuchi, Briana Sargent, Han, D. S., Han, D. S., Han, D. S., Han, D. S., Han, D. S., Ha...> ;Clinical Pharmacology in Drug Development. 2023 Aug 1
17 citations
Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction.
Karin Nelander, Maria Lagerström-Fermér, Carl Amilon, Erik Michaëlsson, Maria Heijer, M Kjaer, Muir Russell, Eva-Lotte Lindstedt, Carl Whatling, Li-Ming Gan, Hans Eric...> ;Clinical and Translational Science. 2021 May 1
18 citations
Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study
Austin G. Stack, Ronald Goldwater, Susanne Johansson, Nalina Dronamraju, Jan Oscarsson, Eva Johnsson, Joanna Parkinson, Fredrik Erlandsson, Han, D. S., Han, D. S., Han...> ;The Journal of Clinical Endocrinology and Metabolism. 2020 Oct 19
11 citations
Single- and Multiple-Dose Safety, Tolerability, and Pharmacokinetic Profiles of ASP8062: Results From 2 Phase 1 Studies.
Mark Walzer, Gerard J. Marek, Ruishan Wu, Masanori Nagata, Han, D. S., David Han> ;Clinical Pharmacology in Drug Development. 2020 Apr 1
19 citations
The Effect of Verapamil, a P-Glycoprotein Inhibitor, on the Pharmacokinetics of Peficitinib, an Orally Administered, Once-Daily JAK Inhibitor.
Tong Zhu, Corrie Howieson, Tomasz Wojtkowski, Jay P. Garg, Ogert Fisniku, James Keirns, Han, D. S., David Han> ;Clinical Pharmacology in Drug Development. 2017 Nov 1
10 citations
Drug Interactions Between Peficitinib, an Orally Administered, Once-Daily Janus Kinase Inhibitor, and Rosuvastatin in Healthy Subjects
Tong Zhu, Barbara Parker, Tomasz Wojtkowski, Tetsuya Nishimura, Jay P. Garg, Ogert Fisniku, James Keirns, Han, D. S., David Han> ;Clinical Pharmacokinetics. 2017 Jul 1
34 citations
Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects
Takao Yamazaki, Amit Desai, Ronald Goldwater, Kenneth C. Lasseter, Corrie Howieson, Shahzad Akhtar, Donna Kowalski, Christopher Lademacher, Diane Rammelsberg, Robert T...> ;Clinical Pharmacology in Drug Development. 2017 Jan 1
90 citations
Pharmacokinetic Assessment of Drug‐Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacroli...
Andreas H. Groll, Amit Desai, Corrie Howieson, Kota Kato, Shahzad Akhtar, Donna Kowalski, Christopher Lademacher, William Lewis, Helene Pearlman, Debra Mandarino, Taka...> ;Clinical Pharmacology in Drug Development. 2017 Jan 1
Join now to see all

Professional Memberships

American Academy of Family Physicians - AAFP
Member

Other Languages

Korean

Hospital Affiliations

Adventist Health GlendaleGlendale, California
USC Verdugo Hills HospitalGlendale, California